Jiangsu Hengrui Medicine Investor Relations Material
Latest events
Q1 2025
25 Apr, 2025
H2 2024
31 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Jiangsu Hengrui Medicine
Access all reports
Jiangsu Hengrui Medicine Co., Ltd. is a China-based pharmaceutical company engaged in the research, development, production, and distribution of innovative medicines. The company focuses on therapeutic areas such as oncology, anesthesiology, cardiology, and endocrinology. It offers a diverse portfolio of pharmaceutical products, including chemical drugs, biologics, and injectables. The company is headquartered in Lianyungang, China, and its shares are listed on the Shanghai Stock Exchange.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
600276
Country
🇨🇳 China